August 10th 2002

  Buy Issue 2639

Articles from this issue:

COVER STORY: The future of the Australian Democrats

Latham steals limelight from lacklustre ALP

New Zealand Labour forced into new coalition

STRAWS IN THE WIND: Rob the Builder / Mayhem in Lilliput / Fear of wages

ECONOMY: New agenda needed to address social breakdown

WA Liberals' new policy positions

Could India help in Afghanistan? (letter)

Clerical scandals: another view (letter)

Families now a luxury (letter)

COMMENT: Stalin's heirs live on ... in Australia

BIOETHICS: American stem cell expert to visit

UNITED STATES: Why Bush ended funding for UN population control agency

LAW: International Criminal Court decision to dog government

BOOKS: Our Posthuman Future, by Francis Fukuyama

BOOKS: The Price of Motherhood, by Ann Crittenden

SOUTH AUSTRALIA: Shirley Nolan: a case for euthanasia?

Books promotion page

American stem cell expert to visit

by News Weekly

News Weekly, August 10, 2002
Dr David Prentice, a leading American expert on stem cell science, will visit Australia this month at the invitation of Do No Harm, a coalition of Australians who support ethical medical research.

Dr Prentice is Professor of Life Sciences at Indiana State University, and Adjunct Professor of Medical and Molecular Genetics for Indiana University School of Medicine.

His research, which has been funded by the National Institutes of Health, investigates cell growth control; one current focus of his laboratory is adult stem cells and their transformation into other tissue types.

He is a Founding Member of Do No Harm: The Coalition of Americans for Research Ethics. He has provided scientific advice for US Senator Sam Brownback one of the co-sponsors of the bill to prohibit cloning.

Dr Prentice has testified several times before the US Congress as well as several state legislatures, and has spoken before the National Academy of Sciences, the British Parliament, the European Parliament, and the Canadian Parliament on stem cell research, cloning, and bioethics.

While in Australia, Dr Prentice will be speaking at public meetings in Sydney (North Sydney Anzac Memorial Club, Wednesday, August 14, 7.30 pm, Tel 02 9267 6159); Brisbane (Parliament House, Brisbane, 1 pm, Thursday, August 15, Tel 07 3252 8255) and Melbourne (Thomas More Centre, North Melbourne, Friday, August 16, 7.45 pm).

He will also be debating Professor Alan Trounson, leading Australian advocate of embryonic stem cell research on the ABC's Lateline program on Wednesday, August 14.

Dr Prentice testified to a Congressional hearing on Embryonic Cell Research that research using stem cells not derived from human embryos has confirmed that these adult and post-natal stem cells have

"vast biomedical potential to cure diseases such as diabetes, Parkinson's, heart disease and other degenerative diseases. The biomedical potential is as great as or greater than the potential offered by human embryonic stem cell research. Adult stem cell research is a preferable alternative for progress in regenerative medicine and cell-based therapies for disease because it does not pose the medical and ethical problems associated with destructive embryonic stem cell research."

He pointed to the tendency of embryonic stem cells to form tumours, their instability in gene expression and the problem of immune rejection as key obstacles that have so far prevented even a single successful treatment using embryonic stem cells. Adult stem cells do not have these problems and have already been used in a range of successful therapies.

Dr Prentice will address MHRs and Senators on this issue at a breakfast meeting in Parliament House, Canberra on August 20.

Do No Harm is confident that Dr Prentice's visit will help to make the public, the media and Federal MPs better informed on the science of stem cell research, leading up to the debate on the Research Involving Human Embryos and Prohibition of Cloning Bill 2002 in the forthcoming session of Federal Parliament.

All you need to know about
the wider impact of transgenderism on society.
TRANSGENDER: one shade of grey, 353pp, $39.99

Join email list

Join e-newsletter list

Your cart has 0 items

Subscribe to NewsWeekly

Research Papers

Trending articles

NATIONAL AFFAIRS Cardinal Pell's appeal in the High Court this week

NATIONAL AFFAIRS Time and timing are crucial to Cardinal Pell's appeal by Peter Westmore

COVER STORY Beyond the Great Divide

COVER STORY Murray River full; reservoirs low; farms for sale ...

ILLICIT DRUGS Cannabis marketed to children in Colorado

COVER STORY The world has changed: Now for the new order

EDITORIAL Holden, China, covid19: Time for industry reset

© Copyright 2017
Last Modified:
April 4, 2018, 6:45 pm